查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
类鸦片物质的全球市场 - 市场占有率·规模·趋势·产业分析:各级，各释出类型，各产品，各用途，各地区，市场区隔预测(2022年～2030年)
市场调查报告书
商品编码
1150071

类鸦片物质的全球市场 - 市场占有率·规模·趋势·产业分析:各级，各释出类型，各产品，各用途，各地区，市场区隔预测(2022年～2030年)

Opioid Market Share, Size, Trends, Industry Analysis Report, By Class (Natural, Semi-synthetic, and fully synthetic); By Release Type; By Product; By Application; By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格

全球类鸦片物质的市场规模在2030年前将达到60亿2,000万美元。

本报告提供全球类鸦片物质市场调查，提供市场概要，市场规模和预测，趋势，促进因素·阻碍因素，各级·各释出类型·各产品·各用途·各地区等分析，再加上企业简介等资讯。

目录

第1章 简介

  • 报告的说明
    • 调查的目的
    • 市场范围
    • 前提条件
  • 利害关係者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资讯来源
    • 一次资讯
    • 二次资讯

第4章 全球类鸦片物质市场洞察

  • 类鸦片物质 - 产业的概述
  • 类鸦片物质市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力
    • 新加入厂商者的威胁
    • 买方议价能力
    • 替代品的威胁
    • 现有企业间的竞争力
  • 大环境分析
  • 类鸦片物质产业趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球类鸦片物质市场:各级

  • 主要调查结果
  • 简介
    • 全球类鸦片物质市场，各级(2018年～2030年)
  • 天然
    • 全球类鸦片物质市场，天然，各地区(2018年～2030年)
  • 半合成
    • 全球类鸦片物质市场，半合成，各地区(2018年～2030年)
  • 完全合成
    • 全球类鸦片物质市场，完全合成，各地区(2018年～2030年)

第6章 全球类鸦片物质市场:各释出类型

  • 主要调查结果
  • 简介
    • 全球类鸦片物质市场，各释出类型(2018年～2030年)
  • 瞬效型/短效型类鸦片物质
    • 全球类鸦片物质市场，瞬效型/短效型类鸦片物质，各地区(2018年～2030年)
  • 缓释型/长效型类鸦片物质
    • 全球类鸦片物质市场，缓释型/长效型类鸦片物质，各地区(2018年～2030年)

第7章 全球类鸦片物质市场:各产品

  • 主要调查结果
  • 简介
    • 全球类鸦片物质市场，各产品(2018年～2030年)
  • 可待因
    • 全球类鸦片物质市场，可待因，各地区(2018年～2030年)
  • 芬太尼
    • 全球类鸦片物质市场，芬太尼，各地区(2018年～2030年)
  • 羟考酮
    • 全球类鸦片物质市场，羟考酮，各地区(2018年～2030年)
  • 美沙酮
    • 全球类鸦片物质市场，美沙酮，各地区(2018年～2030年)
  • 吗啡
    • 全球类鸦片物质市场，吗啡，各地区(2018年～2030年)
  • 氢可酮
    • 全球类鸦片物质市场，吗啡，各地区(2018年～2030年)
  • Tramadol
    • 全球类鸦片物质市场，Tramadol，各地区(2018年～2030年)
  • Propoxyphene
    • 全球类鸦片物质市场，Propoxyphene，各地区(2018年～2030年)
  • 其他
    • 全球类鸦片物质市场，其他，各地区(2018年～2030年)

第8章 全球类鸦片物质市场:各用途

  • 主要调查结果
  • 简介
    • 全球类鸦片物质市场，各用途(2018年～2030年)
  • 疼痛管理
    • 全球类鸦片物质市场，疼痛管理，各地区(2018年～2030年)
    • 神经病变
    • 偏头痛
    • 整形外科·肌肉骨骼
  • 癌症性疼痛
    • 全球类鸦片物质市场，癌症性疼痛，各地区(2018年～2030年)
  • 脑
    • 全球类鸦片物质市场，脑，各地区(2018年～2030年)
    • 胸部
    • 结肠·直肠
    • 血液
    • 皮肤
    • 前列腺
    • 其他
  • 咳嗽治疗
    • 全球类鸦片物质市场，咳嗽不同治疗，各地区(2018年～2030年)
  • 止痛药
    • 全球类鸦片物质市场，止痛药，各地区(2018年～2030年)
  • 腹泻治疗
    • 全球类鸦片物质市场，腹泻不同治疗，各地区(2018年～2030年)
  • 脱中毒
    • 全球类鸦片物质市场，脱中毒，各地区(2018年～2030年)
  • 其他
    • 全球类鸦片物质市场，其他，各地区(2018年～2030年)

第9章 全球类鸦片物质市场:各地区

  • 主要调查结果
  • 简介
    • 类鸦片物质市场评估，各地区(2018年～2030年)
  • 类鸦片物质市场 - 北美
    • 北美:类鸦片物质市场，各级(2018年～2030年)
    • 北美:类鸦片物质市场，各用途(2018年～2030年)
    • 北美:类鸦片物质市场，各释出类型(2018年～2030年)
    • 北美:类鸦片物质市场，各产品(2018年～2030年)
    • 类鸦片物质市场 - 美国
    • 类鸦片物质市场 - 加拿大
  • 类鸦片物质市场 - 欧洲
    • 欧洲:类鸦片物质市场，各级(2018年～2030年)
    • 欧洲:类鸦片物质市场，各用途(2018年～2030年)
    • 欧洲:类鸦片物质市场，各释出类型(2018年～2030年)
    • 欧洲:类鸦片物质市场，各产品(2018年～2030年)
    • 类鸦片物质市场 - 英国
    • 类鸦片物质市场 - 法国
    • 类鸦片物质市场 - 德国
    • 类鸦片物质市场 - 义大利
    • 类鸦片物质市场 - 西班牙
    • 类鸦片物质市场 - 荷兰
    • 类鸦片物质市场 - 俄罗斯
  • 类鸦片物质市场 - 亚太地区
    • 亚太地区:类鸦片物质市场，各级(2018年～2030年)
    • 亚太地区:类鸦片物质市场，各用途(2018年～2030年)
    • 亚太地区:类鸦片物质市场，各释出类型(2018年～2030年)
    • 亚太地区:类鸦片物质市场，各产品(2018年～2030年)
    • 类鸦片物质市场 - 中国
    • 类鸦片物质市场 - 印度
    • 类鸦片物质市场 - 日本
    • 类鸦片物质市场 - 马来西亚
    • 类鸦片物质市场 - 印尼
    • 类鸦片物质市场 - 韩国
  • 类鸦片物质市场 - 中东·非洲
    • 中东·非洲:类鸦片物质市场，各级(2018年～2030年)
    • 中东·非洲:类鸦片物质市场，各用途(2018年～2030年)
    • 中东·非洲:类鸦片物质市场，各释出类型(2018年～2030年)
    • 中东·非洲:类鸦片物质市场，各产品(2018年～2030年)
    • 类鸦片物质市场 - 沙乌地阿拉伯
    • 类鸦片物质市场 - 南非
    • 类鸦片物质市场 - 以色列
    • 类鸦片物质市场 - 阿拉伯联合大公国
  • 类鸦片物质市场 - 南美
    • 南美:类鸦片物质市场，各级(2018年～2030年)
    • 南美:类鸦片物质市场，各用途(2018年～2030年)
    • 南美:类鸦片物质市场，各释出类型(2018年～2030年)
    • 南美:类鸦片物质市场，各产品(2018年～2030年)
    • 类鸦片物质市场 - 墨西哥
    • 类鸦片物质市场 - 巴西
    • 类鸦片物质市场 - 阿根廷

第10章 竞争情形

  • 扩大·收购的分析
    • 扩大
    • 收购
  • 伙伴关係/合作/协定/公开

第11章 企业简介

  • Aurobindo Pharma Limited,
  • Assertio Therapeutics, Inc.
  • AbbVie Inc.
  • Actavis Plc.
  • Amneal Pharmaceuticals LLC
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Limited
  • Fresenius Kabi
  • Mallinckrodt Pharmaceuticals
  • Endo International plc
  • IBM Corporation
  • Lupin Limited
  • Nesher Pharmaceuticals(USA)LLC
  • Purdue Pharma L.P.
  • Pfizer Inc.
  • Rhodes Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Limited
  • Trevena Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: PM1368

The global opioid market size is expected to reach USD 6.02 billion by 2030, according to a new study by Polaris Market Research. The report "Opioid Market Share, Size, Trends, Industry Analysis Report, By Class (Natural, Semi-synthetic, and Fully synthetic); By Release Type; By Product; By Application; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

An increase in the use of these medications to treat pain and an increase in the number of elderly people, who are particularly vulnerable to orthopedic pain, are the main reasons driving the market's expansion. Since chronic pain is widespread in the aged population and is thought to be a separate risk factor for mortality, the aging population is a significant driving force behind the industry's explosive expansion. For instance, the World Health Organization (WHO) projects that by 2050, there will be about 2.0 billion people in the world who are 60 years of age or older, with most of the growth occurring in developing nations. In 2015, there were approximately 900 million people in this age group. France has almost 150 years to adapt to a rise in the percentage of people over 60 from 10% to 20% of the population.

The elderly increasingly suffer from chronic diseases like diabetes due to the growing aging population and changing lifestyles driving demand for cutting-edge healthcare technologies. This has increased industry expansion. Asthma, diabetes, heart disease, cancer, and other conditions that persist for a long time and are frequently incurable are examples of chronic diseases. The three most prevalent medical diagnoses worldwide are asthma, diabetes, and heart disease.

The primary reasons behind the burgeoning chronic conditions are unhealthy lifestyles, alcohol consumption, smoking habits, and physical inactivity. Poverty is also one of the reasons for growth in long-term illness, particularly in underdeveloped regions of the world, such as African nations, Asian countries, and the countries of South America. These long-term illness conditions are the leading cause of disability and death worldwide. The significant population over 65 is reported to have long-term diseases because of irregular lifestyles. Thus, the demand for opioids among the aging population with chronic disease is growing, driving industry growth.

Additionally, there has been a marked increase in the number of persons worldwide who experience chronic pain. The market is expected to rise as a result, according to predictions. For instance, the Centers for Disease Control and Prevention (CDC) 2019 found that 7.4% of Americans had high-impact chronic pain.

Opioid Market Report Highlights

The long-acting opioids segment is anticipated to grow at the highest CAGR over the forecast period. These drugs are frequently used to treat moderate to severe chronic pain. These medications offer therapeutic advantages such as consistent, long-lasting analgesia and reduced dose frequency.

Semi-synthetic opioids segment accounted for to growth rapidly of the global revenue share due to the increased availability and demand for these painkillers. Labs use natural opiates to create semi-synthetic types.

Asia-Pacific is expected to grow prominently over the projected period. This can be attributed to cancer cases rising across several developing economies. Nearly half of cancer's worldwide burden is borne by Asia. Additionally, a growing elderly population and an increase in cases of chronic pain would increase regional market demand.

The global market is highly competitive owing to the existence of prominent players with a worldwide presence, including Aurobindo Pharma Limited, Assertio Therapeutics, Inc., AbbVie Inc., Nesher Pharmaceuticals (USA) LLC, Purdue Pharma L.P., Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Trevena Inc., and Teva Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the Opioid market report based on class, release type, product, application, and region:

Opioid, Class Outlook (Revenue - USD Billion, 2018 - 2030)

Natural

Semi-synthetic

Fully Synthetic

Opioid, Release Type Outlook (Revenue - USD Billion, 2018 - 2030)

Immediate-release/Short-acting

Extended-release/Long-acting

Opioid, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Codeine

Fentanyl

Oxycodone

Methadone

Morphine

Hydrocodone

Tramadol

Propoxyphene

Others

Opioid, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Pain management

Neuropathic

Migraine

Orthopedic and Musculoskeletal

Arthritis

Fibromyalgia

Others

Cancer Pain

Brain

Breast

Colorectal

Blood

Skin

Prostate

Others

Others

Cough treatment

Analgesia

Diarrhea treatment

De-addiction

Others

Opioid, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Opioid Market Insights

  • 4.1. Opioid - Industry Snapshot
  • 4.2. Opioid Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expanding application of opioids in various therapeutic conditions
      • 4.2.1.2. Expanding target audience for the opioid market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Opioid Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Opioid Market, by Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • 5.3. Natural
    • 5.3.1. Global Opioid Market, by Natural, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Semi-synthetic
    • 5.4.1. Global Opioid Market, by Semi-synthetic, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Fully synthetic
    • 5.5.1. Global Opioid Market, by Fully synthetic, by Region, 2018 - 2030 (USD Billion)

6. Global Opioid Market, by Release Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • 6.3. Immediate-release/Short-acting opioid
    • 6.3.1. Global Opioid Market, by Immediate-release/Short-acting opioid, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Extended-release/Long-acting opioid
    • 6.4.1. Global Opioid Market, by Extended-release/Long-acting opioid, by Region, 2018 - 2030 (USD Billion)

7. Global Opioid Market, by Product

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • 7.3. Codeine
    • 7.3.1. Global Opioid Market, by Codeine, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Fentanyl
    • 7.4.1. Global Opioid Market, by Fentanyl, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Oxycodone
    • 7.5.1. Global Opioid Market, by Oxycodone, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Methadone
    • 7.6.1. Global Opioid Market, by Methadone, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Morphine
    • 7.7.1. Global Opioid Market, by Morphine, by Region, 2018 - 2030 (USD Billion)
  • 7.8. Hydrocodone
    • 7.8.1. Global Opioid Market, by Hydrocodone, by Region, 2018 - 2030 (USD Billion)
  • 7.9. Tramadol
    • 7.9.1. Global Opioid Market, by Tramadol, by Region, 2018 - 2030 (USD Billion)
  • 7.10. Propoxyphene
    • 7.10.1. Global Opioid Market, by Propoxyphene, by Region, 2018 - 2030 (USD Billion)
  • 7.11. Others
    • 7.11.1. Global Opioid Market, by Others, by Region, 2018 - 2030 (USD Billion)

8. Global Opioid Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • 8.3. Pain management
    • 8.3.1. Global Opioid Market, by Pain management, by Region, 2018 - 2030 (USD Billion)
    • 8.3.2. Neuropathic
      • 8.3.2.1. Global Opioid Market, by Neuropathic, by Region, 2018 - 2030 (USD Billion)
    • 8.3.3. Migraine
      • 8.3.3.1. Global Opioid Market, by Migraine, by Region, 2018 - 2030 (USD Billion)
    • 8.3.4. Orthopedic and Musculoskeletal
      • 8.3.4.1. Global Opioid Market, by Orthopedic and Musculoskeletal, by Region, 2018 - 2030 (USD Billion)
      • 8.3.4.2. Arthritis
      • 8.3.4.2.1. Global Opioid Market, by Arthritis, by Region, 2018 - 2030 (USD Billion)
      • 8.3.4.3. Fibromyalgia
      • 8.3.4.3.1. Global Opioid Market, by Fibromyalgia, by Region, 2018 - 2030 (USD Billion)
      • 8.3.4.4. Others
      • 8.3.4.4.1. Global Opioid Market, by Others, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Cancer Pain
    • 8.4.1. Global Opioid Market, by Cancer Pain, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Brain
    • 8.5.1. Global Opioid Market, by Brain, by Region, 2018 - 2030 (USD Billion)
    • 8.5.2. Breast
      • 8.5.2.1. Global Opioid Market, by Breast, by Region, 2018 - 2030 (USD Billion)
    • 8.5.3. Colorectal
      • 8.5.3.1. Global Opioid Market, by Colorectal, by Region, 2018 - 2030 (USD Billion)
    • 8.5.4. Blood
      • 8.5.4.1. Global Opioid Market, by Blood, by Region, 2018 - 2030 (USD Billion)
    • 8.5.5. Skin
      • 8.5.5.1. Global Opioid Market, by Skin, by Region, 2018 - 2030 (USD Billion)
    • 8.5.6. Prostate
      • 8.5.6.1. Global Opioid Market, by Prostate, by Region, 2018 - 2030 (USD Billion)
    • 8.5.7. Others
      • 8.5.7.1. Global Opioid Market, by Others, by Region, 2018 - 2030 (USD Billion)
  • 8.6. Cough treatment
    • 8.6.1. Global Opioid Market, by Cough treatment, by Region, 2018 - 2030 (USD Billion)
  • 8.7. Analgesia
    • 8.7.1. Global Opioid Market, by Analgesia, by Region, 2018 - 2030 (USD Billion)
  • 8.8. Diarrhea treatment
    • 8.8.1. Global Opioid Market, by Diarrhea treatment, by Region, 2018 - 2030 (USD Billion)
  • 8.9. De-addiction
    • 8.9.1. Global Opioid Market, by De-addiction, by Region, 2018 - 2030 (USD Billion)
  • 8.10. Others
    • 8.10.1. Global Opioid Market, by Others, by Region, 2018 - 2030 (USD Billion)

9. Global Opioid Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Opioid Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Opioid Market - North America
    • 9.3.1. North America: Opioid Market, by Class, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Opioid Market, by Application, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.3.5. Opioid Market - U.S.
      • 9.3.5.1. U.S.: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.3.6. Opioid Market - Canada
      • 9.3.6.1. Canada: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • 9.4. Opioid Market - Europe
    • 9.4.1. Europe: Opioid Market, by Class, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Opioid Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.5. Opioid Market - UK
      • 9.4.5.1. UK: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.6. Opioid Market - France
      • 9.4.6.1. France: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.7. Opioid Market - Germany
      • 9.4.7.1. Germany: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.8. Opioid Market - Italy
      • 9.4.8.1. Italy: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.9. Opioid Market - Spain
      • 9.4.9.1. Spain: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.10. Opioid Market - Netherlands
      • 9.4.10.1. Netherlands: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.11. Opioid Market - Russia
      • 9.4.11.1. Russia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • 9.5. Opioid Market - Asia Pacific
    • 9.5.1. Asia Pacific: Opioid Market, by Class, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Opioid Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.5. Opioid Market - China
      • 9.5.5.1. China: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.6. Opioid Market - India
      • 9.5.6.1. India: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.7. Opioid Market - Japan
      • 9.5.7.1. Japan: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.8. Opioid Market - Malaysia
      • 9.5.8.1. Malaysia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.9. Opioid Market - Indonesia
      • 9.5.9.1. Indonesia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.10. Opioid Market - South Korea
      • 9.5.10.1. South Korea: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • 9.6. Opioid Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Opioid Market, by Class, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Opioid Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.5. Opioid Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.6. Opioid Market - South Africa
      • 9.6.6.1. South Africa: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.7. Opioid Market - Israel
      • 9.6.7.1. Israel: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.8. Opioid Market - UAE
      • 9.6.8.1. UAE: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • 9.7. Opioid Market - Latin America
    • 9.7.1. Latin America: Opioid Market, by Class, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Opioid Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.7.5. Opioid Market - Mexico
      • 9.7.5.1. Mexico: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.7.6. Opioid Market - Brazil
      • 9.7.6.1. Brazil: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Opioid Market, by Product, 2018 - 2030 (USD Billion)
    • 9.7.7. Opioid Market - Argentina
      • 9.7.7.1. Argentina: Opioid Market, by Class, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Opioid Market, by Application, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Opioid Market, by Product, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Aurobindo Pharma Limited,
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Assertio Therapeutics, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. AbbVie Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Actavis Plc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Amneal Pharmaceuticals LLC
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Boehringer Ingelheim International GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Cadila Healthcare Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Fresenius Kabi
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Mallinckrodt Pharmaceuticals
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Endo International plc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. IBM Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lupin Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Nesher Pharmaceuticals (USA) LLC
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Purdue Pharma L.P.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Pfizer Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Rhodes Pharmaceuticals L.P.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Sun Pharmaceutical Industries Limited
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Trevena Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. Teva Pharmaceutical Industries Ltd.
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development

List of Tables

  • Table 1 Global Opioid Market, by Class, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Opioid Market, by Release Type, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Opioid Market, by Product, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Opioid Market, by Application, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Opioid Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 7 North America: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 8 North America: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 9 North America: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 26 France: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 27 France: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 28 France: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 29 France: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 30 UK: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 31 UK: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 32 UK: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 33 UK: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 46 Russia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 47 Russia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 48 Russia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 49 Russia: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 54 China: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 55 China: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 56 China: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 57 China: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 62 India: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 63 India: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 64 India: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 65 India: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Opioid Market, by Application, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Opioid Market, by Class, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Opioid Market, by Release Type, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Opioid Market, by Product, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Opioid Market, by Application, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Opioid Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Application

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Class

Figure 7. Global Opioid Market, by Class, 2021 & 2030 (USD Billion)

Figure 8. Market by Application

Figure 9. Global Opioid Market, by Application, 2021 & 2030 (USD Billion)

Figure 10. Market by Release Type

Figure 11. Global Opioid Market, by Release Type, 2021 & 2030 (USD Billion)

Figure 12. Market by Product

Figure 13. Global Opioid Market, by Product 2021 & 2030 (USD Billion)

Figure 14. Opioid Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Opioid Market